BYLAWS OF THE SOCIETY OF PROFESSIONAL PHARMACEUTICAL CONSULTANTS
Article I: Name and Purpose
1.1 Name – The name of the organization shall be the Society of Professional Pharmaceutical Consultants (“SOPPhC”).
1.2 Purpose – SOPPhC is a nonprofit business league organized under Section 501(c)(6) of the Internal Revenue Code. Its mission is to promote the professional development, ethical standards, and business interests of pharmaceutical consultants.
Article II: Membership
2.1 Eligibility – Membership shall be open to individuals engaged in pharmaceutical consulting or related fields, subject to application review and approval.
2.2 Categories – The Board may establish membership categories with associated benefits and fees.
2.3 Dues – Annual dues shall be established by the Board of Directors and must be paid in full for active membership.
Article III: Board of Directors
3.1 Authority and Responsibility – The board of Directors shall govern the organization, establish policy, and oversee strategy, operations, and finances.
3.2 Number and Composition – The Board shall consist of no fewer than three (3) and no more than eleven (11) Directors, including Officers.
3.3 Officers – The Officers shall include:
– President (also serves as Executive Director)
– Vice President
– Secretary
– Treasurer
3.4 Election and Term – Directors shall be elected by a majority vote of the membership during the Annual Meeting or through a secure digital voting process. – Directors shall serve two-year terms and may be re-elected for up to three consecutive terms. – Officer roles shall be determined by majority vote of the Board at its first meeting following election.
3.5 Vacancies and Removal – Vacancies may be filled by majority vote of the Board for the remainder of the term.
– A Director may be removed for cause by a two-thirds (2/3) vote of the Board.
3.6 Meetings – The Board shall meet at least quarterly. Special meetings may be called by the President or any three Directors.
– A quorum shall consist of a simple majority of the current Board.
Article IV: Committees
4.1 Standing and Ad Hoc Committees – The Board may establish standing or ad hoc committees to support operations, membership, events, and other needs.
4.2 Advisory Circle – A non-voting Advisory Circle composed of senior pharmaceutical leaders shall provide mentorship, strategic insight, and thought leadership.
Article V: Executive Director
5.1 Role – The Executive Director (President) is responsible for daily operations, executing strategy, managing staff, and reporting to the Board.
5.2 Compensation – The Executive Director may receive compensation as determined by the Board in compliance with nonprofit compensation guidelines.
Article VI: Financial Management
6.1 Fiscal Year – The fiscal year shall be January 1 to December 31.
6.2 Budget and Audit – The Board shall approve an annual budget. Independent financial reviews may be conducted as needed.
6.3 Use of Funds – No part of the net earnings shall benefit any individual. All revenue shall further the mission of SOPPhC.
Article VII: Amendments
7.1 Process These Bylaws may be amended by a two-thirds (2/3) vote of the Board, followed by majority approval of voting members.
Article VII: Dissolution
8.1 Disposition of Assets – Upon dissolution, remaining assets shall be distributed to a 501(c)(6) or 501(c)(3) organization with a similar mission, as determined by the Board.